Meeting News CoverageMeeting News Coverage

Cardioprotective effects of diabetes drugs examined

Endocrine Today, December 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — In the past, research has linked various diabetes medications, including acarbose and insulin, with…
Meeting News CoverageMeeting News Coverage

Role of HDL in predicting, preventing CVD questionable

Endocrine Today, December 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — Using HDL as both a target for treatment and a predictor for cardiovascular disease, has received a…
Meeting News CoveragePerspective

Telephone coaching as effective for weight loss as in-person counseling

Endocrine Today, December 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — Significant and sustained weight loss among participants in a remote telephone- and Web-based…
Meeting News CoverageMeeting News CoveragePerspective

ATLAS ACS: Adding rivaroxaban to antiplatelet therapy reduced death rates in ACS

Endocrine Today, December 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — Rivaroxaban added to standard treatment reduced the risk for CV death, MI and stroke among patients…
Meeting News Coverage

Survival improved over time after pediatric stroke

November 21, 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — New data reveal that 85% of children were alive 5 years after a pediatric stroke. However…
Meeting News Coverage

Exposure to particulate matter raises CVD risk in 'Ground Zero' workers

November 18, 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — High levels of exposure to particulate matter appeared to worsen the atherogenic profiles of workers…
Meeting News Coverage

SWEETHEART: Number of new diabetes cases higher in women

November 17, 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — Women with ST-elevation myocardial infarction and non-ST-elevated myocardial infarction had…
Meeting News Coverage

Full coverage of post-MI drugs reduced vascular event rates, out-of-pocket costs

November 15, 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — Eliminating co-payments for post-MI secondary prevention drugs improved adherence, reduced rates of…
Meeting News Coverage

SATURN and AIM-HIGH: Back down to planet Earth

November 15, 2011
AHA Scientific Sessions 2011 Again this year, clinical trials evaluating lipoprotein-modifying therapies are in the spotlight at the American…
Meeting News Coverage

Evacetrapib boosts HDL, lowers LDL levels

November 15, 2011
AHA Scientific Sessions 2011 ORLANDO, Fla. — Results of a preliminary trial suggest that the experimental drug evacetrapib, administered as…